Cytoplasmic inclusions containing TDP43 are typically observed in 95% of ALS and 50% of FTD patients, regardless of the presence or absence of TARDBP mutations (Bright et al., 2021). Here, TARDBP is linked to amyotrophic lateral sclerosis.